Endpoints and Management in Inflammatory Bowel Disease

Dr. David T. Rubin, Joseph B. Kirsner Professor of Medicine, discusses the preferred outcomes of IBD management and issues with current treatment strategies.  Dr. Rubin also explains the benefits and limitations of therapy approaches and describes the potential future methodologies for drug selection and dosing.  

Related Presenters


David T. Rubin, MD

Co-Director, Digestive Diseases Center

Joseph B. Kirsner Professor of Medicine Section Chief, Gastroenterology, Hepatology and Nutrition Co-Director, Digestive Diseases Center Dr. David Rubin specializes in the treatment and assessment of digestive diseases. His clinical expertise ...

View full profile